Patents by Inventor Gal.la Pericot Mohr

Gal.la Pericot Mohr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRIAMTERENE OR NOLATREXED FOR USE IN THE TREATMENT OF PHENYLKETONURIA
    Publication number: 20220133726
    Abstract: The present invention relates to a compound selected from the group consisting of nolatrexed, triamterene, sultopride and hydrastinine or a pharmaceutically acceptable salt thereof, preferably triamterene, nolatrexed or a pharmaceutically acceptable salt thereof, and to combination of said compounds with other active ingredients, for use in the treatment and/or prevention of phenylketonuria, to the use of said compound or its combinations in the manufacture of a medicament for the treatment or prevention of said diseases and to a method of treating and/or preventing by administration of said compound or its combinations.
    Type: Application
    Filed: February 13, 2020
    Publication date: May 5, 2022
    Inventors: Raúl INSA BORONAT, Núria REIG BOLAÑO, Aileen FERRÉ FERRÉ, Óscar HUERTAS GAMBÍN, Santiago ESTEVA GRAS, Luca SIGNORILE, Gal.la PERICOT MOHR
  • COMPOUND FOR THE TREATMENT OF TUMOURS AND TUMOUR METASTASES
    Publication number: 20150210669
    Abstract: The invention relates to a Smoothened receptor ligand which antagonises the Hedgehog pathway, to pharmaceutical compositions and therapeutic applications thereof, processes for obtaining this compound and novel intermediates useful in these processes.
    Type: Application
    Filed: December 2, 2011
    Publication date: July 30, 2015
    Applicant: SIENA BIOTECH S.P.A.
    Inventors: Gal.la Pericot Mohr, Russel J. Thomas, Giacomo Minetto, Marta Bellini, Paul H. Wiedenau, Matteo Betti
  • Hedgehog pathway antagonists and therapeutic applications thereof
    Patent number: 8835648
    Abstract: Heterocyclic compounds that modulate the hedgehog signaling pathway, pharmaceutical composition thereof and their therapeutic applications.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: September 16, 2014
    Assignee: Siena Biotech S.p.A.
    Inventors: J. Russell Thomas, Gal.la Pericot Mohr, Chiara Caramelli, Giacomo Minetto, Marta Bellini
  • Hedgehog pathway antagonists and therapeutic applications thereof
    Patent number: 8592463
    Abstract: Heterocyclic compounds that modulate the hedgehog signaling pathway, pharmaceutical composition thereof and their therapeutic applications.
    Type: Grant
    Filed: December 10, 2008
    Date of Patent: November 26, 2013
    Assignee: Siena Biotech S.p.A.
    Inventors: Russell John Thomas, Gal.la Pericot Mohr, Giacomo Minetto, Annette Cornelia Bakker, Pietro Ferruzzi
  • HEDGEHOG PATHWAY ANTAGONISTS AND THERAPEUTIC APPLICATIONS THEREOF
    Publication number: 20120088752
    Abstract: Heterocyclic compounds that modulate the hedgehog signaling pathway, pharmaceutical composition thereof and their therapeutic applications.
    Type: Application
    Filed: June 9, 2010
    Publication date: April 12, 2012
    Applicant: SIENA BIOTECH S.p.A.
    Inventors: J. Russell Thomas, Gal.la Pericot Mohr, Chiara Caramelli, Giacomo Minetto, Marta Bellini
  • HEDGEHOG PATHWAY ANTAGONISTS AND THERAPEUTIC APPLICATIONS THEREOF
    Publication number: 20100286114
    Abstract: Heterocyclic compounds that modulate the hedgehog signaling pathway, pharmaceutical composition thereof and their therapeutic applications.
    Type: Application
    Filed: December 10, 2008
    Publication date: November 11, 2010
    Applicant: SIENA BIOTECH S.P.A.
    Inventors: Russell John Thomas, Gal.la Pericot Mohr, Giacomo Minetto, Annette Cornelia Bakker, Pietro Ferruzzi